RNA transport in neurons — Staufen2 detects its target transcripts in a complex manner

A team of scientists from Helmholtz Zentrum München and the University of Ulm has discovered that the neuronal transport factor Staufen2 scans and binds to its target transcripts in a much more complex manner than previously thought. RNA is transported within highly complex protein-RNA particles whose structure and specificity are still poorly understood. The team’s findings, recently published in the journal Nature Communications, opens up new approaches to improve our understanding of the process.

Staufen2 is a neuronal RNA-binding protein that plays an important role in the differentiation of neural progenitor cells during neurogenesis. In addition, it is a key factor in the transport of RNA to synapses and is therefore important for synaptic plasticity, the basis of memory and memory formation.

The team led by Professor Dr. Dierk Niessing, group leader at the Institute of Structural Biology (STB) of Helmholtz Zentrum München and professor and head of the Institute of Pharmaceutical Biotechnology at the University of Ulm, showed that RNA-binding domains (dsRBDs) 1 and 2 of the mStau2 protein bond to mRNA with the same affinity and kinetics as domains 3 and 4. It was previously thought that the latter were in themselves sufficient for mRNA binding. While RNA recognition by each of these so-called tandem domains is transient, all four RNA-binding domains recognize their target RNA with a high degree of stability.

Previous studies had suggested that only two RNA binding domains in Staufen2, namely dsRBD 3 and 4, are responsible for binding. Despite this, until now it proved impossible to reproduce stable binding required for RNA transport in the test tube. “That problem has been solved,” says Niessing, “because it is now clear that dsRBDs 1 and 2 are also needed to create a stable complex. Using various biochemical and biophysical techniques, we were able to explain the behavior of dsRBD 1 and 2 “. “It turns out that Staufen2 recognizes its target RNAs in a much more complex way than previously thought,” adds Dr. Simone Heber, lead author of the article and postdoc at the STB. “Staufen2 scans and binds to its transcripts with four RNA-binding domains in total “. The study was carried out in close collaboration with Professor Michael Sattler, Director of the STB and head of the NMR Center of Helmholtz Zentrum München and the Technical University of Munich, and Dr. Anne Ephrussi, head of the Developmental Biology Unit at the European Molecular Biology Laboratory (EMBL) in Heidelberg.

The Staufen2 protein plays a key role in memory formation and memory persistence, though the process is still not well understood. In an aging society, research on this topic is of paramount importance as it improves our understanding of the molecular underpinnings and principles of learning and memory.

The project is part of the FOR2333 research group, which is funded by the German Research Foundation and headed by Dierk Niessing. The successful funding of the research group in the second funding period was announced in March 2019. Knowledge of the function of Staufen2 contributes significantly to our overall understanding of RNA transport in higher organisms – a function that is also of great interest to stem cell researchers. For this reason, the research team led by Niessing is also collaborating with colleagues at the Institute of Stem Cell Research (ISF).


Further Information

Original publication:

Simone Heber et al. (2019): Staufen2-mediated RNA recognition and localization requires combinatorial action of multiple domains. Nature communications: DOI 10.1038/s41467-019-09655-3 https://www.nature.com/articles/s41467-019-09655-3

As the German research center for health and the environment, Helmholtz Zentrum München pursues the goal of developing personalized medicine for the diagnosis, treatment and prevention of widespread diseases such as diabetes, allergies and lung diseases. To this end, it researches the interplay between genetics, environmental factors and lifestyle. The center’s main site is in Neuherberg in the north of Munich. Helmholtz Zentrum München has around 2,300 employees and is a member of the Helmholtz Association, which encompasses 19 science, technical, medical and biological research centers with around 37,000 employees. http://www.helmholtz-muenchen.de

The Institute of Structural Biology (STB) researches the spatial structure of biological macromolecules, analyzes their structure and dynamics and develops NMR spectroscopy methods for those investigations. The aim is to elucidate molecular mechanisms underlying the biological activity of these molecules and their role in diseases. The structural data serve as a basis for the rational development of small molecular inhibitors using biochemical methods. https://www.helmholtz-muenchen.de/stb/index.html

The Institute of Stem Cell Research (ISF) The ISF investigates the basic molecular and cellular mechanisms of stem cell maintenance and stem cell differentiation. On this basis, the ISF develops approaches for the replacement of degenerated cell types, either by activation of resting stem cells or by re-programming other endogenous cells for repair. The aim of these methods is to stimulate the replacement of damaged, diseased, altered or degenerate tissue. https://www.helmholtz-muenchen.de/isf/index.html

Contact for the media:

Abteilung Kommunikation, Helmholtz Zentrum München -Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH), Ingolstädter Landstraße 1, 85764 Neuherberg, Tel. +49 89 3187-2238, E-Mail: [email protected]

Scientific Contact:

Prof. Dr. Dierk Niessing, Helmholtz Zentrum München – Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH), Institut für Strukturbiologie, Ingolstädter Landstraße 1, 85764 Neuherberg, Tel. +49 89 3187 2176, E-Mail: [email protected]

Media Contact
Sonja Opitz
[email protected]

Original Source


Related Journal Article


Ovarian cancer researchers find biomarker linked to prognosis in aggressive disease type

(TORONTO, Canada – March 7, 2017) – Ovarian cancer researchers have identified a protein biomarker expressed on the surface of tumour cells in high-grade...

Scientists have developed an effective marker for cancer diagnosis and therapy

A research group consisting of scientists from NUST MISIS, the Technical University of Munich, Helmholtz Zentrum München, the University of Duisburg-Essen, and the University...

A protective factor against Alzheimer’s disease?

Researchers at the German Center for Neurodegenerative Diseases (DZNE) and the Institute for Stroke and Dementia Research (ISD) at the University Hospital of the...

Gaps in knowledge of pharmacokinetic changes in pregnancy and their clinical consequences

There is a substantial gap in knowledge of pharmacokinetic changes in pregnancy and their clinical consequences, according to a study published by Shinya Ito...

Diagnostic advance: gas-sensing capsule set to hit market by 2022

An electronic capsule that measures gases in the gut to revolutionise the diagnosis of gut disorders could be available within four years, following an...

How is COVID-19 affecting Holocaust survivors?

Bar-Ilan University study finds that the pandemic can echo past adversities and trigger amplified psychological reactionsHolocaust survivors have exhibited a wide range of emotional...

Shark bites tied for 10-year low in 2022 but spiked in regional hotspots

The number of unprovoked shark attacks worldwide decreased last year, tying with 2020 for the fewest number of reported incidents in the last 10...

Changes in the vascular system may trigger Alzheimer’s disease

As the average age of Americans increases, so too does the problem of Alzheimer's, one of the world's most common neurological diseases. In recent...

Targeting our second brain to fight diabetes

Since 2004, Claude Knauf (INSERM) and Patrice Cani (UCLouvain) have been collaborating on molecular and cellular mechanisms in order to understand the causes of...